IBIO
iBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.31
+0.77%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.63x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 1.68x
Liquidity & coverage
- Current ratio
- 7.85x
- Quick ratio
- 7.85x
- Cash ratio
- 4.80x
- Interest coverage
- -663.04x
- EBITDA / interest
- -610.28x
- Working capital
- $80.5M
Cash & dividend
- FCF / debt
- -10.83x
- Cash flow / debt
- -10.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026